To establish a paradigm for multiplexed gene editing in primary human cord blood-derived hematopoietic stem and progenitor cells, investigators used co-delivery of lentiviral sgRNA vectors, together with Cas9 mRNA, to simultaneously edit two genetic loci.
[Blood Cancer Journal]